MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0105094
Pharmachem Biotech (I) Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.79 Cr
▲ 72% YoY
Net loss · FY 2025
₹71.62 Lakh
Net margin -10.6%
EBITDA · FY 2025
-₹66.29 Lakh
EBITDA margin -9.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Pharmachem Biotech (I) Private Limited
Data last updated:
Pharmachem Biotech (I) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC300701. Its GSTIN is 24AAJCP4772C1ZH (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.5 Lakh. It was formerly known as Pharmachem Bio India Private Limited. It is led by directors including Anand Ganpatbhai Trivedi and Hersal Bharat Parmar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 502/A 5th Floor Narmada Enclave Chs Shimpoli Rd No. 1 Borivali West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.79 Cr, a growth of 72% compared to the previous year. For the same year it recorded a net loss of ₹71.62 Lakh (net margin -10.6%) and EBITDA of -₹66.29 Lakh (EBITDA margin -9.8%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 14% over five years.
Pharmachem Biotech (I) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0105094). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmachemindia.in.
Company details
CIN U74999MH2017PTC300701
Registration Number 300701
Incorporation Date 11 October 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0105094
Key People
Anand Ganpatbhai Trivedi Director Hersal Bharat Parmar Director Amitkumar Ganpatbhai Trivedi Director Recognitions & Rankings of Pharmachem Biotech (I)
Contact details
Pharmachem Biotech (I) Private Limited's registered office is in Mumbai, Maharashtra. Its website is pharmachemindia.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address502/A 5th Floor Narmada Enclave Chs Shimpoli Rd No. 1 Borivali West, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pharmachem Biotech (I) Private Limited, buy the company report.
Comprehensive company report
Pharmachem Biotech (I) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pharmachem Biotech (I) is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Pharmachem Biotech (I) Private Limited, buy the company report.
Financials of Pharmachem Biotech (I) Private Limited
FY 2025 filings availablePharmachem Biotech (I) Private Limited reported revenue of ₹6.79 Cr (up 72% YoY) for FY 2025.
Revenue · FY 2025
₹6.79 Cr ▲ 72%
Net loss · FY 2025
₹71.62 Lakh margin -10.6%
EBITDA · FY 2025
-₹66.29 Lakh margin -9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 72%
3 years · compounded
▼ 27%
5 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 41%
5 years · compounded
▼ 26%
Revenue rose 72% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹66.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹71.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.8% | ||||
| Net Profit Margin | -10.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmachem Biotech (I) Private Limited, buy the company report.
Board of directors of Pharmachem Biotech (I) Private Limited
Pharmachem Biotech (I) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Ganpatbhai Trivedi Also directs: Ambix Healthcare LLP, Welvita Healthcare Private Limited, S.G.Biopharm Private Limited and 1 more | Director | 11 Oct 2017 | 9 Years 1 Months | Current |
| Hersal Bharat Parmar | Director | 08 Mar 2019 | 7 Years 8 Months | Current |
| Amitkumar Ganpatbhai Trivedi | Director | 11 Oct 2017 | 9 Years 1 Months | Current |
Auditor
Pharmachem Biotech (I) Private Limited is audited by S N & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S N & Co. | FY 2023 | 128887W |
Shareholding
The shareholding of Pharmachem Biotech (I) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmachem Biotech (I) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmachem Biotech (I) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Pharmachem Biotech (I) Private Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 187 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Refinics Consultants LLP | |||
| Invochem Laboratory | |||
| an individual supplier | |||
| Paper & Allied Products |
To see the full MSME payment records of Pharmachem Biotech (I) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Pharmachem Biotech (I) has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCP4772C1ZH | Gujarat | Active | 24 Sep 2018 |
To see the full GST registrations and return filing status of Pharmachem Biotech (I) Private Limited, buy the company report.
Recent activity
Pharmachem Biotech (I) Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Hersal Bharat Parmar ceased to be Additional Director on 30 Sep 2019.
AGM
Pharmachem Biotech (I) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharmachem Biotech (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Hersal Bharat Parmar ceased to be Additional Director.
Appointed
Hersal Bharat Parmar was appointed as Director.
Appointed
Amitkumar Ganpatbhai Trivedi was appointed as Director.
Appointed
Anand Ganpatbhai Trivedi was appointed as Director.
Incorporation
11 Oct 2017
Pharmachem Biotech (I) Private Limited was registered on 11 Oct 2017 with Roc Mumbai & aged 9 years 1 month as per MCA records.
Frequently asked questions
Pharmachem Biotech (I) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 October 2017 (9+ years old) and is registered under CIN U74999MH2017PTC300701.
Pharmachem Biotech (I) has 3 current directors:
- Anand Ganpatbhai Trivedi - Director
- Hersal Bharat Parmar - Director
- Amitkumar Ganpatbhai Trivedi - Director
The latest financial statements of Pharmachem Biotech (I) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Pharmachem Biotech (I) is 24AAJCP4772C1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Pharmachem Biotech (I) is U74999MH2017PTC300701. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmachem Biotech (I) was incorporated on 11 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Hersal Bharat Parmar ceased to be Additional Director on 30 Sep 2019. Hersal Bharat Parmar was appointed as Director on 08 Mar 2019. Amitkumar Ganpatbhai Trivedi was appointed as Director on 11 Oct 2017. Pharmachem Biotech (I) has 4 board changes on record in total.
Yes, Pharmachem Biotech (I) is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0105094).
Pharmachem Biotech (I) has 13 MSME Form 1 returns on record between 2019 and 2023, listing 187 overdue payments to 34 micro and small suppliers. The latest return was filed on 31 Oct 2023.
Pharmachem Biotech (I) can be reached through the website pharmachemindia.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Pharmachem Biotech (I) is at 502A 5th Floor Narmada Enclave Chs Shimpoli Rd No. 1 Borivali West, Mumbai, Maharashtra, India – 400092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages